207 related articles for article (PubMed ID: 18722326)
1. Skin-autofluorescence, a measure of tissue advanced glycation end-products (AGEs), is related to diastolic function in dialysis patients.
Hartog JW; Hummel YM; Voors AA; Schalkwijk CG; Miyata T; Huisman RM; Smit AJ; Van Veldhuisen DJ
J Card Fail; 2008 Sep; 14(7):596-602. PubMed ID: 18722326
[TBL] [Abstract][Full Text] [Related]
2. Simple non-invasive assessment of advanced glycation endproduct accumulation.
Meerwaldt R; Graaff R; Oomen PHN; Links TP; Jager JJ; Alderson NL; Thorpe SR; Baynes JW; Gans ROB; Smit AJ
Diabetologia; 2004 Jul; 47(7):1324-1330. PubMed ID: 15243705
[TBL] [Abstract][Full Text] [Related]
3. Plasma advanced glycation end-products and skin autofluorescence are increased in COPD.
Gopal P; Reynaert NL; Scheijen JL; Engelen L; Schalkwijk CG; Franssen FM; Wouters EF; Rutten EP
Eur Respir J; 2014 Feb; 43(2):430-8. PubMed ID: 23645408
[TBL] [Abstract][Full Text] [Related]
4. Advanced Glycation End Product (AGE) Accumulation in the Skin is Associated with Depression: The Maastricht Study.
van Dooren FE; Pouwer F; Schalkwijk CG; Sep SJ; Stehouwer CD; Henry RM; Dagnelie PC; Schaper NC; van der Kallen CJ; Koster A; Denollet J; Verhey FR; Schram MT
Depress Anxiety; 2017 Jan; 34(1):59-67. PubMed ID: 27271340
[TBL] [Abstract][Full Text] [Related]
5. Nepsilon-(carboxymethyl)lysine, Nepsilon-(carboxyethyl)lysine and vascular cell adhesion molecule-1 (VCAM-1) in relation to peritoneal glucose prescription and residual renal function; a study in peritoneal dialysis patients.
van de Kerkhof J; Schalkwijk CG; Konings CJ; Cheriex EC; van der Sande FM; Scheffer PG; ter Wee PM; Leunissen KM; Kooman JP
Nephrol Dial Transplant; 2004 Apr; 19(4):910-6. PubMed ID: 15031349
[TBL] [Abstract][Full Text] [Related]
6. The role of advanced glycation end-products and their receptor on outcome in heart failure patients with preserved and reduced ejection fraction.
Willemsen S; Hartog JW; van Veldhuisen DJ; van der Meer P; Roze JF; Jaarsma T; Schalkwijk C; van der Horst IC; Hillege HL; Voors AA
Am Heart J; 2012 Nov; 164(5):742-749.e3. PubMed ID: 23137505
[TBL] [Abstract][Full Text] [Related]
7. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients.
Meerwaldt R; Hartog JW; Graaff R; Huisman RJ; Links TP; den Hollander NC; Thorpe SR; Baynes JW; Navis G; Gans RO; Smit AJ
J Am Soc Nephrol; 2005 Dec; 16(12):3687-93. PubMed ID: 16280473
[TBL] [Abstract][Full Text] [Related]
8. Tissue advanced glycation end products are associated with diastolic function and aerobic exercise capacity in diabetic heart failure patients.
Willemsen S; Hartog JW; Hummel YM; van Ruijven MH; van der Horst IC; van Veldhuisen DJ; Voors AA
Eur J Heart Fail; 2011 Jan; 13(1):76-82. PubMed ID: 20861128
[TBL] [Abstract][Full Text] [Related]
9. Left ventricular function in patients with chronic kidney disease evaluated by colour tissue Doppler velocity imaging.
Hayashi SY; Rohani M; Lindholm B; Brodin LA; Lind B; Barany P; Alvestrand A; Seeberger A
Nephrol Dial Transplant; 2006 Jan; 21(1):125-32. PubMed ID: 16221719
[TBL] [Abstract][Full Text] [Related]
10. Circulating levels and dietary intake of the advanced glycation end-product marker carboxymethyl lysine in chronic kidney disease patients on conservative predialysis therapy: a pilot study.
Piroddi M; Palazzetti I; Quintaliani G; Pilolli F; Montaldi M; Valentina V; Libetta C; Galli F
J Ren Nutr; 2011 Jul; 21(4):329-39. PubMed ID: 21193322
[TBL] [Abstract][Full Text] [Related]
11. Plasma levels of advanced glycation end products are associated with haemolysis-related organ complications in sickle cell patients.
Nur E; Brandjes DP; Schnog JJ; Otten HM; Fijnvandraat K; Schalkwijk CG; Biemond BJ;
Br J Haematol; 2010 Oct; 151(1):62-9. PubMed ID: 20678158
[TBL] [Abstract][Full Text] [Related]
12. Diastolic dysfunction of aging is independent of myocardial structure but associated with plasma advanced glycation end-product levels.
Campbell DJ; Somaratne JB; Jenkins AJ; Prior DL; Yii M; Kenny JF; Newcomb AE; Schalkwijk CG; Black MJ; Kelly DJ
PLoS One; 2012; 7(11):e49813. PubMed ID: 23189164
[TBL] [Abstract][Full Text] [Related]
13. Serum advanced glycation endproducts are associated with left ventricular dysfunction in normal glucose metabolism but not in type 2 diabetes: The Hoorn Study.
Linssen PB; Henry RM; Schalkwijk CG; Dekker JM; Nijpels G; Brunner-La Rocca HP; Stehouwer CD
Diab Vasc Dis Res; 2016 Jul; 13(4):278-85. PubMed ID: 27190078
[TBL] [Abstract][Full Text] [Related]
14. Pentosidine, carotid atherosclerosis and alterations in left ventricular geometry in hemodialysis patients.
Zoccali C; Mallamaci F; Asahia K; Benedetto FA; Tripepi G; Tripepi R; Nicocia G; Buemi M; Miyata T
J Nephrol; 2001; 14(4):293-8. PubMed ID: 11506253
[TBL] [Abstract][Full Text] [Related]
15. Skin autofluorescence is increased in systemic lupus erythematosus but is not reflected by elevated plasma levels of advanced glycation endproducts.
Nienhuis HL; de Leeuw K; Bijzet J; Smit A; Schalkwijk CG; Graaff R; Kallenberg CG; Bijl M
Rheumatology (Oxford); 2008 Oct; 47(10):1554-8. PubMed ID: 18701539
[TBL] [Abstract][Full Text] [Related]
16. Plasma advanced glycosylation end-products in maintenance haemodialysis patients.
Odetti P; Cosso L; Pronzato MA; Dapino D; Gurreri G
Nephrol Dial Transplant; 1995 Nov; 10(11):2110-3. PubMed ID: 8643178
[TBL] [Abstract][Full Text] [Related]
17. The influence of gender, weight, height and BMI on pentosidine concentrations in plasma of hemodialyzed patients.
Slowick-Zylka D; Safranow K; Dziedziejko V; Dutkiewicz G; Ciechanowski K; Chlubek D
J Nephrol; 2006; 19(1):65-9. PubMed ID: 16523428
[TBL] [Abstract][Full Text] [Related]
18. Two fluorescent wavelengths, 440(ex)/520(em) nm and 370(ex)/440(em) nm, reflect advanced glycation and oxidation end products in human skin without diabetes.
Beisswenger PJ; Howell S; Mackenzie T; Corstjens H; Muizzuddin N; Matsui MS
Diabetes Technol Ther; 2012 Mar; 14(3):285-92. PubMed ID: 22023375
[TBL] [Abstract][Full Text] [Related]
19. Clinical and prognostic value of advanced glycation end-products in chronic heart failure.
Hartog JW; Voors AA; Schalkwijk CG; Scheijen J; Smilde TD; Damman K; Bakker SJ; Smit AJ; van Veldhuisen DJ
Eur Heart J; 2007 Dec; 28(23):2879-85. PubMed ID: 17986469
[TBL] [Abstract][Full Text] [Related]
20. Are advanced glycation end products cardiovascular risk factors in patients with CRF?
Stein G; Busch M; Müller A; Wendt T; Franke C; Niwa T; Franke S
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S52-6. PubMed ID: 12612953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
